Synairgen plc (AIM: SNG)
London
· Delayed Price · Currency is GBP · Price in GBX
2.480
-1.265 (-33.78%)
Dec 20, 2024, 12:18 PM GMT+1
Synairgen Statistics
Total Valuation
Synairgen has a market cap or net worth of GBP 4.05 million. The enterprise value is -4.54 million.
Market Cap | 4.05M |
Enterprise Value | -4.54M |
Important Dates
The next estimated earnings date is Friday, December 27, 2024.
Earnings Date | Dec 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Synairgen has 202.66 million shares outstanding. The number of shares has increased by 0.01% in one year.
Current Share Class | n/a |
Shares Outstanding | 202.66M |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | -0.01% |
Owned by Insiders (%) | 2.07% |
Owned by Institutions (%) | 25.50% |
Float | 141.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.42 |
P/TBV Ratio | 0.43 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.66 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 0.69 |
Financial Position
The company has a current ratio of 9.76
Current Ratio | 9.76 |
Quick Ratio | 9.76 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.24% and return on invested capital (ROIC) is -42.53%.
Return on Equity (ROE) | -54.24% |
Return on Assets (ROA) | -36.99% |
Return on Capital (ROIC) | -42.53% |
Revenue Per Employee | n/a |
Profits Per Employee | -192,306 |
Employee Count | 36 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.89% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -65.89% |
50-Day Moving Average | 4.53 |
200-Day Moving Average | 4.96 |
Relative Strength Index (RSI) | 19.11 |
Average Volume (20 Days) | 337,522 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -8.69M |
Pretax Income | -8.11M |
Net Income | -6.92M |
EBITDA | -8.64M |
EBIT | -8.69M |
Earnings Per Share (EPS) | -0.03 |
Balance Sheet
Cash & Cash Equivalents | 8.59M |
Total Debt | n/a |
Net Cash | 8.59M |
Net Cash Per Share | 0.04 |
Equity (Book Value) | 9.56M |
Book Value Per Share | 0.05 |
Working Capital | 9.45M |
Cash Flow
In the last 12 months, operating cash flow was -6.61 million and capital expenditures -12,000, giving a free cash flow of -6.62 million.
Operating Cash Flow | -6.61M |
Capital Expenditures | -12,000 |
Free Cash Flow | -6.62M |
FCF Per Share | -0.03 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Synairgen does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.01% |
Shareholder Yield | -0.01% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |